Responses
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0216 Long-Term Safety and Efficacy of Mavrilimumab, A Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-Alpha Monoclonal Antibody, in Patients with Rheumatoid Arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.